Depot medroxyprogesterone acetate (DMPA) can prevent pregnancy for up to three months, and is available in a form that can be ...
“Since most physicians don’t know that this is an option, patients don’t know about it. It’s safe, effective, and puts the ...
A new contraceptive option provides a possible answer to an age-old question in family planning: how to address barriers that make it difficult for women to keep using contraception consistently.
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman’s risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three ...
"This is an exciting milestone for women in the United Kingdom, and, potentially, in countries around the world, who might prefer this method of contraception and mode of administration." Pfizer Inc.
To compare longitudinal changes in weight, body fat, and ratio of central to peripheral fat mass among first-time depot-medroxyprogesterone acetate (DMPA) users to women using no hormonal ...
Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer to an age-old question in family planning: how to address barriers that make it ...